A Kales, E O Bixler, T L Tan, M B Scharf, J D Kales. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultAge FactorsAgedAmobarbital/therapeutic useChloral Hydrate/therapeutic useChronic DiseaseDreams/drug effectsDrug Therapy, CombinationFemaleFlurazepam/therapeutic useHumansHypnotics and Sedatives/administration & dosageHypnotics and Sedatives/therapeutic useMaleMiddle AgedPentobarbital/therapeutic useSecobarbital/therapeutic useSleep DeprivationSleep Initiation and Maintenance Disorders/drug therapySleep, REM/drug effectsSodium/therapeutic useSubstance Withdrawal SyndromeSubstance-Related DisordersTime FactorsWakefulness
Substances: See more » Hypnotics and SedativesSecobarbitalChloral HydrateSodiumAmobarbitalPentobarbitalFlurazepam
Year: 1974 PMID: 4358882
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272